Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

A Novel Assay of Neutrophil Extracellular Traps (NETs) Formation Independently Predicts DIC and Identifies the Rationale for Anti-IL-8 Therapies

Simon Timothy Abrams, PhD BSc, Ben Morton, MBChB, MD, Yasir Alhamdi, MBChB, PhD, Mohmad Alsabani, Zhenxing Cheng, Steven Lane, PhD, Ingeborg Welters, PhD, Guozheng Wang, MD PhD, Cheng-Hock Toh, MD

Blood (2019) 134 (Supplement_1): 440.

https://doi.org/10.1182/blood-2019-128493

Published: 2019

Journal Articles

Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Baseline Disease Severity

Paul Coppo, MD PhD, Spero Cataland, MD, Flora Peyvandi, MD PhD, Paul Knoebl, MD, Marie Scully, Johanna A. Kremer Hovinga, MD Prof, Ara Metjian, MD, Javier De La Rubia, Katerina Pavenski, MD, Hilde De Winter, MD, Rui de Passos Sousa, Filip Callewaert

Blood (2019) 134 (Supplement_1): 2366.

https://doi.org/10.1182/blood-2019-123720

Published: 2019

Journal Articles

Doxycycline Combined with Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Patients with Mayo 2004 Stage II-III Light-Chain Amyloidosis: A Randomized Controlled Multicenter Study

Kaini Shen, MD, Yujun Dong, MD, Weijun Fu, Sr., MD PhD, Yu Wu, MD, Zhongxia Huang, Yongqiang Wei, PhD, Chunrui Li, MD PhD, Chunyan Sun, MD PhD, Wenrong Huang, Huihan Wang, MD PhD, Congli Zhang, Huilei Miao, Lu Zhang, MD, Xinxin Cao, MD, Daobin Zhou, MD, Jian Li, MD

Blood (2019) 134 (Supplement_1): 1870.

https://doi.org/10.1182/blood-2019-122087

Published: 2019

Journal Articles

Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Marie Scully, MD, Spero R Cataland, MD, Flora Peyvandi, MD PhD, Paul Coppo, MD PhD, Paul Knöbl, MD PhD, Johanna A. Kremer Hovinga, MD, Ara Metjian, MD, Javier de la Rubia, MD, Katerina Pavenski, MD, Filip Callewaert, PhD, Debjit Biswas, PhD, Hilde De Winter, MD, Robert K. Zeldin, MD

Blood (2017) 130 (Supplement 1): LBA-1.

https://doi.org/10.1182/blood.V130.Suppl_1.LBA-1.LBA-1

Published: 2017

Journal Articles

Biomarker-Based Screening of Organ Dysfunction in Patients with MGUS Allows Early Diagnosis of AL Amyloidosis

Giovanni Palladini, MDPhD, Marco Basset, MD, Paolo Milani, MD, Marzia Varettoni, MD, Silvia Mangiacavalli, MD, Francesca Russo, MD, Andrea Foli, MD, Alessandro Corso, MD, Giampaolo Merlini, MD

Blood (2017) 130 (Supplement 1): 1760.

https://doi.org/10.1182/blood.V130.Suppl_1.1760.1760

Published: 2017

Journal Articles

Autologous Stem Cell Transplant (ASCT) Improves the Prognosis of AL Amyloidosis By Inducing a Higher Organ Response Rates and May be Preferred As First Line Treatment Both in AL and in AL Associated with Multiple Myeloma (MM)

Angelo Belotti, MD, Rossella Ribolla, MD, Claudia Crippa, Vincenza Orlando, PharmD, Mariella D'Adda, MD, Alessandro Re, MD, Enrico Morello, MD, Chiara Cattaneo, MD, Giuseppe Rossi

Blood (2016) 128 (22): 4634.

https://doi.org/10.1182/blood.V128.22.4634.4634

Published: 2016

Journal Articles

Updated Results of a Phase 2 Study of Bendamustine in Combination with Dexamethasone (Ben/Dex) in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis

Suzanne Lentzsch, MD PhD, Raymond L. Comenzo, MD, Jeffrey A Zonder, MD, Keren Osman, MD, Miao Susanna, Daniel Backenroth, Daniel Otap, Wei-Yann Tsai, Siva Pregja, Shahzad Raza, MD, Vaishali Sanchorawala, MD, Heather J Landau, MD

Blood (2015) 126 (23): 3041.

https://doi.org/10.1182/blood.V126.23.3041.3041

Published: 2015

Journal Articles

Phase 2 Study of Bendamustine in Combination with Dexamethasone (Ben/Dex) in Patients with Previously-Treated Systemic Light Chain (AL) Amyloidosis

Suzanne Lentzsch, MD PhD, Raymond L. Comenzo, MD, Keren Osman, MD, Kevin Zikaras, BS, Daniel Backenroth, Wei-Yann Tsai, Vaishali Sanchorawala, MD, Heather Landau, MD

Blood (2014) 124 (21): 3480.

https://doi.org/10.1182/blood.V124.21.3480.3480

Published: 2014

Journal Articles

Dysregulation Of Thrombotic and Hemostatic Factors In End Stage Renal Disease

Vinod Bansal, MD, Debra Hoppensteadt, Ph.D., Syed Ahmed, Jawed Fareed, Ph.D.

Blood (2013) 122 (21): 4793.

https://doi.org/10.1182/blood.V122.21.4793.4793

Published: 2013

Journal Articles

Treatment of AL Amyloidosis with Bendamustine

Giovanni Palladini, Stefan O Schonland, MD, Paolo Milani, Christoph Kimmich, MD, Andrea Foli, Tilmann Bochtler, MD, Giampaolo Merlini, Ute Hegenbart, MD

Blood (2012) 120 (21): 4057.

https://doi.org/10.1182/blood.V120.21.4057.4057

Published: 2012

Journal Articles

Orthotopic Heart Transplant Facilitated Autologous Hematopoietic Stem Cell Transplantation in Light-Chain Amyloidosis

Rammurti Kamble, MD, George Carrum, MD, Lawrence Rice, MD, John J. McCarthy, MD, Kelty R. Baker, MD, Carlos A. Ramos, MD, Horacio Adrogue, MD, Jerry Estep, MD

Blood (2011) 118 (21): 4489.

https://doi.org/10.1182/blood.V118.21.4489.4489

Published: 2011

Journal Articles

Increases In B-Type Natriuretic Peptide (BNP) During Treatment with Lenalidomide In AL Amyloidosis

Umit Tapan, MD, David C Seldin, MD, PhD, Kathleen T Finn, ANP, Salli Fennessey, CRA, Anthony C Shelton, RN, Jerome B. Zeldis, MD, PhD, Vaishali Sanchorawala, MD

Blood (2010) 116 (21): 3021.

https://doi.org/10.1182/blood.V116.21.3021.3021

Published: 2010

Journal Articles

Host Prothrombin and Fibrinogen Support S. Aureus Virulence In the Context of Acute Bacteremia

Matthew J. Flick, PhD, Xinli Du, PhD, Leslie Fausnacht, Harini Raghu, Kathryn E Talmage, Keith W Kombrinck, Elizabeth A. Blevins, Eric S. Mullins, MD, Joseph S. Palumbo, MD, Jay L. Degen, PhD

Blood (2010) 116 (21): 821.

https://doi.org/10.1182/blood.V116.21.821.821

Published: 2010

Journal Articles

The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis

Giovanni Palladini, Alessandra Barassi, Catherine Klersy, Rosana Pacciolla, Paolo Milani, Gabriele Sarais, Stefano Perlini, Riccardo Albertini, Paola Russo, Andrea Foli, Letizia Zenone Bragotti, Laura Obici, Remigio Moratti, Gian Vico Melzi d'Eril, Giampaolo Merlini

Blood (2010) 116 (18): 3426–3430.

https://doi.org/10.1182/blood-2010-05-286567

Published: 2010

Includes: Supplemental data

Journal Articles

High-Sensitivity Troponin Assay Improves the Detection of Cardiac Involvement in AL Amyloidosis and Is the Most Powerful Prognostic Determinant.

Giovanni Palladini, Alessandra Barassi, Gabriele Sarais, Ruggero Capra, Andrea Foli, Paola Russo, Riccardo Albertini, Letizia Zenone Bragotti, Laura Obici, Stefano Perlini, Remigio Moratti, Gian Vico Melzi D'Eril, Giampaolo Merlini

Blood (2009) 114 (22): 1782.

https://doi.org/10.1182/blood.V114.22.1782.1782

Published: 2009

Journal Articles

Treatment with Oral Melphalan and Dexamethasone of An Extended Patient Population with AL Amyloidosis.

Giovanni Palladini, Paola Russo, Andrea Foli, Letizia Zenone Bragotti, Francesca Lavatelli, Vittorio Perfetti, Laura Obici, Stefano Perlini, Giampaolo Merlini

Blood (2009) 114 (22): 3889.

https://doi.org/10.1182/blood.V114.22.3889.3889

Published: 2009

Journal Articles

A Phase II Trial of Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) in Previously Treated Patients with AL Amyloidosis.

Giovanni Palladini, Paola Russo, Letizia Zenone Bragotti, Andrea Foli, Francesco Musca, Francesca Lavatelli, Vittorio Perfetti, Laura Obici, Stefano Perlini, Giampaolo Merlini

Blood (2009) 114 (22): 2863.

https://doi.org/10.1182/blood.V114.22.2863.2863

Published: 2009

Journal Articles

Prevention Effects of Schisandrin B on Cardiotoxicity Induced by Anthracyclines in Rabbit Model

Caigang Xu, Feifei Che, Juan Xu, Yu Liu

Blood (2008) 112 (11): 5030.

https://doi.org/10.1182/blood.V112.11.5030.5030

Published: 2008

Journal Articles

Role of Brain-Type Natriuretic Peptide and Cardiac Troponins as Predictors of Outcome in Multiple Myeloma

Ebru Koca, Gaurav Parikh, Ali Imran Amjad, Floralyn L Mendoza, Chitra M Hosing, Uday Popat, Richard E Champlin, Sergio Giralt, Muzaffar H. Qazilbash

Blood (2008) 112 (11): 4457.

https://doi.org/10.1182/blood.V112.11.4457.4457

Published: 2008

Journal Articles

Natriuretic Peptides as Well as Endothelin, and Not Troponin Are of Value in Early Diagnosis of Acute Cardiotoxicity in Children Undergoing Hematopoietic Stem Cell Transplantation

Agnieszka Zaucha-Prazmo, Katarzyna Drabko, Elzbieta Sadurska, Jerzy R Kowalczyk

Blood (2008) 112 (11): 4300.

https://doi.org/10.1182/blood.V112.11.4300.4300

Published: 2008

NARROW

A Novel Assay of Neutrophil Extracellular Traps (NETs) Formation Independently Predicts DIC and Identifies the Rationale for Anti-IL-8 Therapies

Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Baseline Disease Severity

Doxycycline Combined with Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Patients with Mayo 2004 Stage II-III Light-Chain Amyloidosis: A Randomized Controlled Multicenter Study

Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Biomarker-Based Screening of Organ Dysfunction in Patients with MGUS Allows Early Diagnosis of AL Amyloidosis

Autologous Stem Cell Transplant (ASCT) Improves the Prognosis of AL Amyloidosis By Inducing a Higher Organ Response Rates and May be Preferred As First Line Treatment Both in AL and in AL Associated with Multiple Myeloma (MM)

Updated Results of a Phase 2 Study of Bendamustine in Combination with Dexamethasone (Ben/Dex) in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis

Phase 2 Study of Bendamustine in Combination with Dexamethasone (Ben/Dex) in Patients with Previously-Treated Systemic Light Chain (AL) Amyloidosis

Dysregulation Of Thrombotic and Hemostatic Factors In End Stage Renal Disease

Treatment of AL Amyloidosis with Bendamustine

Orthotopic Heart Transplant Facilitated Autologous Hematopoietic Stem Cell Transplantation in Light-Chain Amyloidosis

Increases In B-Type Natriuretic Peptide (BNP) During Treatment with Lenalidomide In AL Amyloidosis

Host Prothrombin and Fibrinogen Support S. Aureus Virulence In the Context of Acute Bacteremia

The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis

High-Sensitivity Troponin Assay Improves the Detection of Cardiac Involvement in AL Amyloidosis and Is the Most Powerful Prognostic Determinant.

Treatment with Oral Melphalan and Dexamethasone of An Extended Patient Population with AL Amyloidosis.

A Phase II Trial of Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) in Previously Treated Patients with AL Amyloidosis.

Prevention Effects of Schisandrin B on Cardiotoxicity Induced by Anthracyclines in Rabbit Model

Role of Brain-Type Natriuretic Peptide and Cardiac Troponins as Predictors of Outcome in Multiple Myeloma

Natriuretic Peptides as Well as Endothelin, and Not Troponin Are of Value in Early Diagnosis of Acute Cardiotoxicity in Children Undergoing Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only